Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression in shikonin-induced HeLa cell apoptosis

Chinese Medical Journal

Volumn 118, Issue 8, 2005, Pages 671-677

  Wu, Zhen ^a   Wu, Li Jun ^a   Tashiro, Shinichi ^b   Onodera, Satoshi ^b   Ikejima, Takashi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Pharmaceutical University   (Japan)

Author keywords

Apoptosis; Extracellular signal regulated kinase; HeLa cells; p53; Shikonin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN P53; SHIKONIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HELA CELL; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

APOPTOSIS; CASPASES; CELL PROLIFERATION; DNA DAMAGE; FLAVONOIDS; HELA CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NAPHTHOQUINONES; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 17844402016     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cohen GM. Caspase: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
2. Han Z, Pantazis P, Wyche JH, et al. A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line. J Biol Chem 2001; 276: 38748-38754.
3. 2+: a control point for apoptosis. Science 2003; 300: 135-139.
4. Widmann C, Gibson S, Jarpe MB, et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-180.
5. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-186.
6. Bergmann A, Agapite J, McCall K, et al. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 1998; 95: 331-341.
7. MacKeigan JP, Collins TS, Ting JP. MEK inhibition enhances paclitaxel-induced tumor apoptosis. J Biol Chem 2000; 275: 38953-38956.
8. Wang XT, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000; 275: 39435-39443.
9. Zhang Y, Wu L, Tashiro S, et al. Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis. Acta Pharmacol Sin 2004; 25: 83-89.
10. Tanaka S, Tajima M, Tsukada M, et al. A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin. J Nat Prod 1986; 49: 466-469.
11. Wang WJ, Bai JY, Liu DP, et al. The antiinflammatory activity of shikonin and its inhibitory effect on leukotriene B4 biosynthesis. Acta Pharmaceutica Sinica (Chin) 1994; 29: 161-165.
12. Sankawa U, Ebizuka Y, Miyazaki T, et al. Antitumor activity of shikonin and its derivatives. Chem Pharm Bull 1977; 25: 2392-2395.
13. Hashimoto S, Xu M, Masuda Y, et al. betahydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide. J Biochem 1999; 125: 17-23.
14. Yoon Y, Kim Y, Lim N, et al. Shikonin, an ingredient of lithospermum erythrorhizon induced apoptosis in HL60 human premyelocytic leukemia cell line. Planta Medica 1999; 65: 532-535.
15. She Q, Chen N, Dong Z. ERKs and p38 kinase phosphorylation p53 protein at serine 15 in response to UV radiation. J Biol Chem 2000; 275: 20444-20449.
16. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
17. Hoshino R, Tanimura S, Watanabe K, et al. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated. J Biol Chem 2001; 276: 2686-2692.
18. Unger T, Sionov RV, Moallem E, et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 1999; 18: 3205-3212.
19. Dumaz N, Meek DW. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 1999; 18: 7002-7010.
20. Colman MS, Afshari CA, Barrett JC. Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res 2000; 462: 179-188.
21. Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281: 1674-1677.
22. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, et al. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 1996; 16: 1722-1733.
23. Karpinich NO, Tafani M, Rothman RJ, et al. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 2002; 277: 16547-16552.